Ovoca Bio reported EUR5.71M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
ALKERMES USD 8.73B 2.85B Jun/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Great Western Mining Corporation EUR 2.58M 666.82K Dec/2025
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
IQVIA Holdings USD 32.25B 3.62B Jun/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Organon & Co USD 3.56B 1.99B Jun/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Revvity USD 12.69B 2.75B Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Viatris USD 18.49B 2.76B Jun/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026